Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Investing

CVS stock drops 13% as company replaces CEO Karen Lynch with David Joyner

admin by admin
October 18, 2024
in Investing
0
CVS stock drops 13% as company replaces CEO Karen Lynch with David Joyner
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

In a major leadership shift, CVS Health has named longtime executive David Joyner as its new CEO, replacing Karen Lynch.

The decision comes as CVS faces significant profit struggles, driven by rising medical costs and a drop in consumer spending at its retail pharmacies.

The announcement, made on Friday, follows a nearly 20% decline in CVS shares this year, with the stock plunging 13% in premarket trading after the leadership change was disclosed.

The company has been grappling with challenges in its insurance unit, Aetna, where higher-than-expected medical costs have weighed on profitability.

In August, CVS cut its full-year profit guidance and revealed plans to trim $2 billion in costs over the next few years to stabilize its financial performance.

CVS stock: company cites medical benefit ratio of 95.2%

In its latest statement, CVS provided guidance for the third quarter, forecasting adjusted earnings between $1.05 and $1.10 per share.

The company also cited an expected medical benefit ratio of 95.2%—higher than previously anticipated due to ongoing cost pressures in its healthcare segment. Investors were cautioned not to rely on prior earnings guidance, given the continued strain on the company’s health benefits unit.

CVS is scheduled to release its third-quarter earnings report on November 6, a key date for investors awaiting more clarity on the company’s financial direction.

The leadership change follows growing pressure from Glenview Capital, a major CVS shareholder, which has been advocating for significant changes at the company.

Reports also surfaced last month that CVS’s board was working with strategic advisors to explore various options, including a potential breakup of its insurance and retail divisions.

David Joyner, who previously led CVS’s pharmacy services as president of CVS Caremark, is expected to bring deep industry expertise to the CEO role.

Joyner started his career at Aetna in pharmacy benefits and has held several senior leadership positions within CVS.

His appointment is seen as a strategic move to navigate the company through its current challenges and unlock future value.

“We believe David’s deep understanding of our integrated business will allow us to tackle the challenges our industry faces and accelerate the operational improvements needed,” said Chairman Roger Farah, who will now assume the role of executive chairman.

Karen Lynch, who stepped down from her position as CEO, also resigned from the company’s board.

Joyner will now take a seat on the board as part of the leadership transition.

As CVS works to restore investor confidence and improve profitability, the new leadership under Joyner aims to steer the company through this critical phase of transformation.

The post CVS stock drops 13% as company replaces CEO Karen Lynch with David Joyner appeared first on Invezz

Previous Post

Volvo’s Q3 earnings fall short: stagnant demand raises alarm for future growth

Next Post

Long PPG: PPG Industries Reports Record Q3 Earnings, Bullish Rejection Pattern Suggests Retest of $137

admin

admin

Next Post
Long PPG: PPG Industries Reports Record Q3 Earnings, Bullish Rejection Pattern Suggests Retest of $137

Long PPG: PPG Industries Reports Record Q3 Earnings, Bullish Rejection Pattern Suggests Retest of $137

Trending News

Bill Ackman takes a massive stake in Uber—what’s driving his bet?

Bill Ackman takes a massive stake in Uber—what’s driving his bet?

February 8, 2025
Meme coin mania: top 3 cryptos that dominated 2024

Meme coin mania: top 3 cryptos that dominated 2024

December 29, 2024
Exclusive-Shell faces delay in German refinery stake sale, sources say

Exclusive-Shell faces delay in German refinery stake sale, sources say

September 19, 2024
Subscribe to Insightful Word


    Recent News

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    June 26, 2025
    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    June 26, 2025
    S&P 500 nears record high as Wall Street opens higher amid tech momentum

    S&P 500 nears record high as Wall Street opens higher amid tech momentum

    June 26, 2025
    Galaxy Digital launches $175 million fund to back DeFi and stablecoin startups

    Galaxy Digital launches $175 million fund to back DeFi and stablecoin startups

    June 26, 2025

    Recent News

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    June 26, 2025
    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    June 26, 2025

    Latest News

    • S&P 500 nears record high despite headwinds: key drivers behind the surprise rally
    • Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high
    • S&P 500 nears record high as Wall Street opens higher amid tech momentum

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.